Indrayani Biotech Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 43,917 shares,. Its Average Traded Price (ATP) is ₹7.93, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2862 @ ₹8.15.
Indrayani Biotech has an upper circuit limit of ₹8.42 and a lower circuit limit of ₹7.62. The total value traded stands at ₹3.48 L, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 1. Indrayani Biotech also offers a dividend yield of 0%.
Indrayani Biotech Share Price Chart
Indrayani Biotech Share Key Metrics
Volume
43917.00
Market Cap
37.11 CR
LTQ@LTP
2862@8.15
ATP
7.93
Var Margin
100 %
Circuit Range
7.62-8.42
Delivery %
100 %
Value
3.48 L
ASM/GSM
No
Market Lot
1
Indrayani Biotech Resistance and Support
Pivot 8.13
Resistance
First Resistance
8.28
Second Resistance
8.55
Third Resistance
8.7
Support
First Support
7.86
Second Support
7.71
Third Support
7.44
Indrayani Biotech Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Indrayani Biotech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-07 | Quarterly Results |
| 2026-08-17 | Audited Results |
| 2026-04-09 | Scheme of Arrangement |
| 2026-02-26 | Quarterly Results |
| 2025-12-11 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-30 | Others |
| 2025-08-14 | Quarterly Results |
| 2025-06-12 | Audited Results |
| 2025-06-09 | Audited Results |
| 2025-04-03 | Rights issue of Equity Shares |
| 2025-02-27 | Quarterly Results |
| 2025-02-14 | Quarterly Results |
| 2024-11-14 | Quarterly Results & Rights issue |
| 2024-08-14 | Quarterly Results |
| 2024-07-27 | Others |
| Rights Date | Ratio | |
|---|---|---|
| 2026-04-28 | 5:7 | View More |
Indrayani Biotech News
Indrayani Biotech Ltd - 526445 - Board Meeting Outcome for Board Meeting Outcome For Unaudited Standalone & Consolidated Financial Results For The Quarter Ended 30Th June 2026 Along With Limited Review Report.
Indrayani Biotech reported Q1 FY27 cons. revenue of ₹37.71 crores and a net profit of ₹0.54 crores, reflecting YoY growth of 29.5% and 245% respectively. Additionally, the board approved the reconstitution of key committees, including the Rights Issue Committee.
Oct 07 2026 17:58:17
Indrayani Biotech Ltd - 526445 - Sale Of Shares Of Subsidiary Company Under Regulation 30 Of SEBI LODR 2015
Indrayani Biotech has completed the sale of a 1.83% stake in its subsidiary, Dindigul Farm Product Limited, through the open market. Following this transaction, the company's shareholding in the entity stands at 27.05%.
Sep 30 2026 23:58:12
Indrayani Biotech Ltd - 526445 - Board Meeting Intimation for Board Meeting Intimation For Board Meeting Intimation For Intimation For Board Meeting To Be Held On 7Th October, 2026
Indrayani Biotech has scheduled a board meeting on October 7, 2026. The agenda includes the consideration of financial results and the reconstitution of various board committees.
Sep 30 2026 18:04:23
Indrayani Biotech Management
| Name | Position |
|---|---|
| NM Ranganathan | Chairman |
| Kasiraman Sayee Sundar | Managing Director |
Indrayani Biotech FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in INDRANIB
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC